1.Korean Diabetes Association. 2023 Clinical practice guide-lines for diabetes. 8th ed.Seoul: Korean Diabetes Association;2023. p. 372–80.
2.Foster NC., Beck RW., Miller KM., Clements MA., Rickels MR., DiMeglio LA, et al. State of type 1 diabetes man-agement and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019. 21:66–72.
Article
3.Beck RW., Riddlesworth TD., Ruedy K., Ahmann A., Haller S., Kruger D., DIAMOND Study Group, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017. 167:365–74.
Article
4.Ruedy KJ., Parkin CG., Riddlesworth TD., Graham C; DIAMOND Study Group. Continuous glucose monitoring in older adults with type 1 and type 2 diabetes using multiple daily injections of insulin: results from the DIAMOND trial. J Diabetes Sci Technol. 2017. 11:1138–46.
Article
5.Yaron M., Roitman E., Aharon-Hananel G., Landau Z., Ganz T., Yanuv I, et al. Effect of flash glucose monitoring tech-nology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019. 42:1178–84.
Article
6.Choe HJ., Rhee EJ., Won JC., Park KS., Lee WY., Cho YM. Effects of patient-driven lifestyle modification using intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: results from the randomized open-label PDF study. Diabetes Care. 2022. 45:2224–30.
Article
7.Yoo HJ., An HG., Park SY., Ryu OH., Kim HY., Seo JA, et al. Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract. 2008. 82:73–9.
Article
8.American Diabetes Association Professional Practice Committee. 6. Glycemic goals and hypoglycemia: stan-dards of care in diabetes-2024. Diabetes Care. 2024. 47(Suppl 1):S111–25.
9.Battelino T., Danne T., Bergenstal RM., Amiel SA., Beck R., Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019. 42:1593–603.
10.Yamamoto JM., Murphy HR. Benefits of real-time contin-uous glucose monitoring in pregnancy. Diabetes Technol Ther. 2021. 23(S1):S8–14.
Article